Cutler Group’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-55,800
Closed -$3K 5517
2021
Q3
$3K Buy
55,800
+49,700
+815% +$2.72M ﹤0.01% 4789
2021
Q2
$33K Buy
+6,100
New +$225K ﹤0.01% 2840
2021
Q1
Sell
-2,700
Closed -$81K 5777
2020
Q4
$81K Sell
2,700
-7,200
-73% -$296K ﹤0.01% 1669
2020
Q3
$14K Buy
+9,900
New +$322K ﹤0.01% 2727
2020
Q1
Sell
-6,000
Closed -$2K 4145
2019
Q4
$2K Buy
+6,000
New +$150K ﹤0.01% 3424
2019
Q3
Sell
-1,000
Closed -$1K 4200
2019
Q2
$1K Hold
1,000
﹤0.01% 3824
2019
Q1
$2K Sell
1,000
-8,800
-90% -$199K ﹤0.01% 3359
2018
Q4
$3K Hold
9,800
﹤0.01% 3157
2018
Q3
$30K Hold
9,800
﹤0.01% 1961
2018
Q2
$68K Sell
9,800
-6,700
-41% -$237K 0.01% 1407
2018
Q1
$89K Sell
16,500
-5,400
-25% -$192K 0.01% 1264
2017
Q4
$104K Buy
21,900
+13,800
+170% +$348K ﹤0.01% 1347
2017
Q3
$23K Sell
8,100
-28,100
-78% -$535K ﹤0.01% 2997
2017
Q2
$65K Buy
36,200
+33,100
+1,068% +$597K ﹤0.01% 2225
2017
Q1
$3K Buy
+3,100
New +$64.2K ﹤0.01% 5099

Other funds holding EDIT

Cutler Group's EDIT Position: Q1 2023 in Review

Cutler Group sold out of Editas Medicine (EDIT) in Q1 2023, closing a stake of 100 shares.

Cutler Group first reported a position in EDIT in Q1 2017 and held it in 24 quarters. The position peaked at $409K in Q4 2021. 234 funds tracked by Wall St. Rank hold EDIT as of Q1 2023.

  • Cutler Group reported no remaining Editas Medicine position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 100 Editas Medicine shares in Q1 2023.
  • Cutler Group first reported a position in Editas Medicine in Q1 2017 and held it in 24 quarters.
  • Cutler Group's Editas Medicine position peaked at $409K in Q4 2021.
  • 234 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.